Yanping Gui

机构：China Pharmaceutical University · ORCID：0000-0001-9209-8452

发表论文 7 篇 · 总被引 116 次 · h-index 5

代表论文

• c-Fos regulated by TMPO/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer (2024 · Cell Death and Disease · 被引 34)
• AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma (2022 · Oncogene · 被引 34)
• GL-V9 reverses adriamycin resistance in hepatocellular carcinoma cells by affecting JNK2-related autophagy (2020 · Chinese Journal of Natural Medicines · 被引 21)
• miR-1258 Attenuates Tumorigenesis Through Targeting E2F1 to Inhibit PCNA and MMP2 Transcription in Glioblastoma (2021 · Frontiers in Oncology · 被引 15)
• Glioma–astrocyte connexin43 confers temozolomide resistance through activation of the E2F1/ERCC1 axis (2024 · Neuro-Oncology · 被引 12)
• MiR-646 inhibited cell proliferation and migration by targeting P62 in glioma (2025 · Cell Adhesion & Migration)